And surprisingly, high-dose Vc is found to be more efficient in killing CRC cells and tumors from xenografts with relatively high MALAT1 expression, which indicates that MALAT1 could be a new marker in directions of using high-dose Vc in treating CRC. The gene discussed is MALAT1; the disease is colorectal carcinoma.